These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24285284)

  • 1. Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study.
    Shim YS; Pae CU; Cho KJ; Kim SW; Kim JC; Koh JS
    Int J Impot Res; 2014; 26(2):76-80. PubMed ID: 24285284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot study.
    Shim YS; Pae CU; Kim SW; Kim HW; Kim JC; Koh JS
    Int J Impot Res; 2011; 23(3):109-14. PubMed ID: 21544084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.
    Ortaç M; Çayan S; Çalişkan MK; Yaman MÖ; Okutucu TM; Semerci MB; Altay AB; Balbay MD; Özcan MF; Kadioğlu A
    Andrology; 2013 Jul; 1(4):549-55. PubMed ID: 23785019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A therapeutic confirmatory study to assess the safety and efficacy of Zydena (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus.
    Moon du G; Yang DY; Lee CH; Ahn TY; Min KS; Park K; Park JK; Kim JJ
    J Sex Med; 2011 Jul; 8(7):2048-61. PubMed ID: 21554549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Min KS; Park K; Park JK
    Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial.
    Park HJ; Park JK; Park K; Min K; Park NC
    J Sex Med; 2010 Jun; 7(6):2209-2216. PubMed ID: 20412426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of udenafil for the treatment of erectile dysfunction after total mesorectal excision of rectal cancer: a randomized, double-blind, placebo-controlled trial.
    Park SY; Choi GS; Park JS; Kim HJ; Park JA; Choi JI
    Surgery; 2015 Jan; 157(1):64-71. PubMed ID: 25482466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction.
    Paick JS; Kim SW; Yang DY; Kim JJ; Lee SW; Ahn TY; Choi HK; Suh JK; Kim SC
    J Sex Med; 2008 Apr; 5(4):946-953. PubMed ID: 18221288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of once-daily administration of udenafil for 24 weeks on erectile dysfunction: results from a randomized multicenter placebo-controlled clinical trial.
    Moon KH; Ko YH; Kim SW; Moon du G; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Chung WS; Min KS; Park JK; Yang DY; Park K
    J Sex Med; 2015 May; 12(5):1194-201. PubMed ID: 25736397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
    Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
    J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction.
    Park SH; Park SW; Cha BY; Park IeB; Min KW; Sung YA; Kim TH; Lee JM; Park KS
    Asian J Androl; 2015; 17(1):143-8. PubMed ID: 25155105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of udenafil for erectile dysfunction: a meta-analysis of randomized controlled trials.
    Ding H; Du W; Wang H; Zhang L; Wang Z; Du C; Tao Y
    Urology; 2012 Jul; 80(1):134-9. PubMed ID: 22497982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction.
    Park HJ; Kim SW; Kim JJ; Lee SW; Paick JS; Ahn TY; Park K; Park JK; Park NC
    J Korean Med Sci; 2017 Jun; 32(6):1016-1023. PubMed ID: 28480661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase 3 Study to Evaluate the 1-Year Efficacy and Safety of Udenafil 75 mg Once Daily in Patients With Erectile Dysfunction.
    Moon KH; Kim SW; Moon du G; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Chung WS; Min KS; Park JK; Yang DY; Shin HS; Park K
    J Sex Med; 2016 Aug; 13(8):1263-9. PubMed ID: 27319276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can PDE5 inhibitors boost brain function?
    Clyne M
    Nat Rev Urol; 2014 Feb; 11(2):65. PubMed ID: 24346005
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic administration of udenafil, a selective phosphodiesterase type 5 inhibitor, promotes erectile function recovery in an animal model of bilateral cavernous nerve crush injury.
    Lee CH; Kim HS; Goo MJ; Kang KK; Ahn BO; Kim SH; Yang DY
    J Sex Med; 2011 May; 8(5):1330-40. PubMed ID: 21366883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of udenafil [Zydena] for the treatment of erectile dysfunction in hypertensive men taking concomitant antihypertensive agents.
    Paick JS; Kim SW; Park YK; Hyun JS; Park NC; Lee SW; Park K; Moon KH; Chung WS
    J Sex Med; 2009 Nov; 6(11):3166-76. PubMed ID: 19694927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in Korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Park HJ; Choi HK; Ahn TY; Park JK; Chung WS; Lee SW; Kim SW; Hyun JS; Park NC
    J Sex Med; 2010 Aug; 7(8):2842-50. PubMed ID: 20626604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Udenafil for the Treatment of Pulmonary Arterial Hypertension: a Placebo-controlled, Double-blind, Phase IIb Clinical Trial.
    Chang HJ; Song S; Chang SA; Kim HK; Jung HO; Choi JH; Lee JS; Kim KH; Jeong JO; Lee JH; Kim DK
    Clin Ther; 2019 Aug; 41(8):1499-1507. PubMed ID: 31202506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.